Key Events This Week
1 June: Strong quarterly turnaround reported with record net sales and profits
1 June: Downgrade to Strong Sell amid mixed financial and technical signals
2 June: Valuation shift prompts upgrade from Strong Sell to Hold
5 June: Week closes at Rs.77.52, up 1.00% for the week

Aarey Drugs & Pharmaceuticals Ltd is Rated Hold
2026-06-12 10:10:05Aarey Drugs & Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Below All Moving Averages and Now at Lower Circuit: Aarey Drugs & Pharmaceuticals Ltd Loses 4.7% in a Single Session
2026-06-11 11:00:16At Rs 74.51, sellers were still queuing — but there were no buyers willing to take the other side. Aarey Drugs & Pharmaceuticals Ltd locked at its lower circuit of 5% on 11 Jun 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock.
Read full news article











